Nature Communications (May 2022)
PERSIST platform provides programmable RNA regulation using CRISPR endoRNases
Abstract
Gene circuits must resist epigenetic silencing for reliable therapeutic applications. Here the authors develop an RNA-level regulation platform using CRISPR endoRNases that is modular, scalable, and more stable than traditional transcriptional versions.